Paper34849607
Functional assessment of somatic STK11 variants identified in primary human non-small cell lung cancers.
Donnelly LL and 13 others. Carcinogenesis, 2021. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Functional assessment of somatic STK11 variants identified in primary human non-small cell lung cancers. Papers, record 34849607. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34849607
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Functional assessment of somatic STK11 variants identified in primary human non-small cell lung cancers.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| AMP-Activated Protein Kinase Kinases | Major topic |
| Carcinoma, Non-Small-Cell Lung | Major topic |
| Lung Neoplasms | Major topic |
| Mutation | Major topic |
| Alternative Splicing | |
| Biomarkers, Tumor | |
| CRISPR-Cas Systems | |
| DNA Mutational Analysis | |
| Disease Susceptibility | |
| Gene Editing | |
| Gene Expression Regulation, Neoplastic | |
| Genetic Predisposition to Disease | |
| Humans | |
| Mutagenesis, Site-Directed | |
| Mutation, Missense | |
| Phosphorylation | |
| Prognosis | |
| RNA Splice Sites |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Department of Pathology and Laboratory Medicine | PubMed | |||
| Department of Biomedical and Health Sciences | PubMed | |||
| UVMMC Department of Pathology and Laboratory Medicine | PubMed |
Source PubMed
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21411391 | A novel de novo mutation in LKB1 gene in a Chinese Peutz Jeghers syndrome patient significantly diminished p53 activity. | Clin Res Hepatol Gastroenterol | 2011 | https://conductscience.org/library/papers/21411391 | PubMed |
| 2 | 28168189 | Historical Evolution of Second-Line Therapy in Non-Small Cell Lung Cancer. | Front Med (Lausanne) | 2017 | https://conductscience.org/library/papers/28168189 | PubMed |
| 3 | 28099846 | Cell of Origin Links Histotype Spectrum to Immune Microenvironment Diversity in Non-small-Cell Lung Cancer Driven by Mutant Kras and Loss of Lkb1. | Cell Rep | 2017 | https://conductscience.org/library/papers/28099846 | PubMed |
| 4 | 16707622 | Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. | Clin Cancer Res | 2006 | https://conductscience.org/library/papers/16707622 | PubMed |
| 5 | 12097271 | Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. | Cancer Res | 2002 | https://conductscience.org/library/papers/12097271 | PubMed |
| 6 | 25717368 | Interpretation of mRNA splicing mutations in genetic disease: review of the literature and guidelines for information-theoretical analysis. | F1000Res | 2014 | https://conductscience.org/library/papers/25717368 | PubMed |
| 7 | 21317932 | A new role of NUAK1: directly phosphorylating p53 and regulating cell proliferation. | Oncogene | 2011 | https://conductscience.org/library/papers/21317932 | PubMed |
| 8 | 25737507 | Immunohistochemical Loss of LKB1 Is a Biomarker for More Aggressive Biology in KRAS-Mutant Lung Adenocarcinoma. | Clin Cancer Res | 2015 | https://conductscience.org/library/papers/25737507 | PubMed |
| 9 | 30376034 | VarSome: the human genomic variant search engine. | Bioinformatics | 2019 | https://conductscience.org/library/papers/30376034 | PubMed |
| 10 | 30885352 | Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11. | Lung Cancer | 2019 | https://conductscience.org/library/papers/30885352 | PubMed |
| 11 | 9837816 | Loss of LKB1 kinase activity in Peutz-Jeghers syndrome, and evidence for allelic and locus heterogeneity. | Am J Hum Genet | 1998 | https://conductscience.org/library/papers/9837816 | PubMed |
| 12 | 9425897 | Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. | Nat Genet | 1998 | https://conductscience.org/library/papers/9425897 | PubMed |
| 13 | 17606980 | PD-1 and PD-1 ligands: from discovery to clinical application. | Int Immunol | 2007 | https://conductscience.org/library/papers/17606980 | PubMed |
| 14 | 29773717 | STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma. | Cancer Discov | 2018 | https://conductscience.org/library/papers/29773717 | PubMed |
| 15 | 32273511 | p53-mediated control of aspartate-asparagine homeostasis dictates LKB1 activity and modulates cell survival. | Nat Commun | 2020 | https://conductscience.org/library/papers/32273511 | PubMed |
| 16 | 26833127 | STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment. | Cancer Res | 2016 | https://conductscience.org/library/papers/26833127 | PubMed |
| 17 | 23637231 | LKB1 represses focal adhesion kinase (FAK) signaling via a FAK-LKB1 complex to regulate FAK site maturation and directional persistence. | J Biol Chem | 2013 | https://conductscience.org/library/papers/23637231 | PubMed |
| 18 | 22658128 | Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. | N Engl J Med | 2012 | https://conductscience.org/library/papers/22658128 | PubMed |
| 19 | 23499923 | Interpretation, stratification and evidence for sequence variants affecting mRNA splicing in complete human genome sequences. | Genomics Proteomics Bioinformatics | 2013 | https://conductscience.org/library/papers/23499923 | PubMed |
| 20 | 19892943 | Structure of the LKB1-STRAD-MO25 complex reveals an allosteric mechanism of kinase activation. | Science | 2009 | https://conductscience.org/library/papers/19892943 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42927193 | Dual Checkpoint Inhibition With or Without Chemotherapy in Metastatic NSCLC: A Reconstructed Individual Patient Data Meta-Analysis. | JTO Clin Res Rep | 2026 | https://conductscience.org/library/papers/42927193 | PubMed |
| 42738366 | STK11/LKB1 Loss in Cancer: From Developmental Constraint to Stress-Adapted Malignancy. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42738366 | PubMed |
| 42545603 | STK11 c.1062 C > G germline variant in medullary thyroid carcinoma: implications for familial predisposition and genetic counseling. | Endocrine | 2026 | https://conductscience.org/library/papers/42545603 | PubMed |
| 41061927 | Genome-wide CRISPR screen identifies STK11 as a critical regulator of sialic acid clusters important for influenza A virus attachment. | J Adv Res | 2026 | https://conductscience.org/library/papers/41061927 | PubMed |
| 40897601 | Clinical and Genomic Features and Prognostic Biomarkers of Oligometastatic Nonsmall Cell Lung Cancer. | Clin Lung Cancer | 2025 | https://conductscience.org/library/papers/40897601 | PubMed |
| 40791513 | Comprehensively Testing the Function of Missense Variation in the STK11 Tumour Suppressor. | bioRxiv | 2025 | https://conductscience.org/library/papers/40791513 | PubMed |
| 39934475 | Evaluating predictors of kinase activity of STK11 variants identified in primary human non-small cell lung cancers. | Hum Genet | 2025 | https://conductscience.org/library/papers/39934475 | PubMed |
| 37968341 | STK11 loss leads to YAP1-mediated transcriptional activation in human KRAS-driven lung adenocarcinoma cell lines. | Cancer Gene Ther | 2024 | https://conductscience.org/library/papers/37968341 | PubMed |
| 35527776 | Role of STK11 in ALK-positive non-small cell lung cancer. | Oncol Lett | 2022 | https://conductscience.org/library/papers/35527776 | PubMed |
Genes12
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34849607
GET https://conductscience.org/api/papers/v1/34849607/references?page=2